Perrigo Company PLC
NYSE:PRGO
Perrigo Company PLC
Total Liabilities & Equity
Perrigo Company PLC
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Perrigo Company PLC
NYSE:PRGO
|
Total Liabilities & Equity
$10.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-3%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Total Liabilities & Equity
$11.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
17%
|
CAGR 10-Years
14%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Total Liabilities & Equity
$167.9m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Total Liabilities & Equity
$226.3m
|
CAGR 3-Years
237%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Total Liabilities & Equity
€759.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
12%
|
|
Ovoca Bio PLC
LSE:OVB
|
Total Liabilities & Equity
€11.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-13%
|
See Also
What is Perrigo Company PLC's Total Liabilities & Equity?
Total Liabilities & Equity
10.6B
USD
Based on the financial report for Mar 30, 2024, Perrigo Company PLC's Total Liabilities & Equity amounts to 10.6B USD.
What is Perrigo Company PLC's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
-3%
Over the last year, the Total Liabilities & Equity growth was -3%. The average annual Total Liabilities & Equity growth rates for Perrigo Company PLC have been -2% over the past three years , -1% over the past five years , and -3% over the past ten years .